Last Updated: May 11, 2026

Profile for South Africa Patent: 202100373


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Africa Patent: 202100373

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Jan 18, 2033 Servier TIBSOVO ivosidenib
⤷  Start Trial Jan 18, 2033 Servier TIBSOVO ivosidenib
⤷  Start Trial Aug 19, 2033 Servier TIBSOVO ivosidenib
⤷  Start Trial Jan 18, 2033 Servier TIBSOVO ivosidenib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for South Africa Patent ZA202100373

Last updated: August 3, 2025


Introduction

Patent ZA202100373 pertains to a pharmaceutical invention filed within South Africa’s patent system. This document aims to provide a comprehensive examination of the patent’s scope, claims, and the broader patent landscape as it relates to this patent. Understanding these components is critical for stakeholders—including generic manufacturers, pharma companies, and legal professionals—seeking to assess patent validity, infringement risk, and competitive positioning within South Africa's pharmaceutical sector.


Scope of Patent ZA202100373

The scope of a patent delineates the breadth of legal protection conferred by the granted patent. It hinges on the claims section, but an understanding of the description and embodiments also elucidates the inventive territory.

Patent Type and Classification:
ZA202100373 is classified as a pharmaceutical patent, likely aligned with the International Patent Classification (IPC) codes relevant to drugs and therapeutic agents, possibly including A61K (preparations for medical, dental, or hygienic purposes).

Subject Matter Overview:
The patent appears centered on a novel formulation, process, or compound with therapeutic utility. While the precise nature depends on the detailed claims—often reflecting innovative chemistry, delivery systems, or specific uses—the scope generally encompasses:

  • Novel chemical entities or derivatives
  • Formulations with enhanced bioavailability or stability
  • Methodologies for manufacturing or administering the drug
  • Specific therapeutic applications or combinations

Claims Analysis

The claims section defines the legal boundaries of the patent's protection. In ZA202100373, the claims likely include:

Independent Claims

  • Chemical Compound Claims:
    Claiming a specific chemical entity or set of entities with defined structural formulas or molecular features. For example, a compound with a particular functional group arrangement designed for enhanced efficacy.

  • Method-of-Use Claims:
    Patents often include claims on the method of administering the compound for targeted indications, such as treating a specific disease condition.

  • Process Claims:
    Covering the synthesis or formulation process that produces the compound or drug delivery system.

  • Formulation Claims:
    Covering particular compositions, such as controlled-release forms, or combination therapies.

Dependent Claims

Dependent claims specify particular embodiments, such as specific substituents, dosage forms, or administration routes, narrowing the scope to particular implementations.

Claim Strengths and Limitations:

  • The breadth of independent claims determines the scope of protection; broader claims provide stronger market exclusivity but risk validity challenges if they cover obvious modifications.
  • Narrow claims limit patent scope but may be more defensible against prior art.

Patent Landscape and Comparative Analysis

Global Patent Context:
The South African patent landscape for pharmaceuticals is shaped by prior patents filed in major jurisdictions like the US, Europe, and China. Similar patents—covering compounds, formulations, or methods—exist in these markets.

For instance, if the patent relates to a novel anticancer compound, review of prior art in the US Patent and Trademark Office (USPTO) and the European Patent Office (EPO) reveals the scope of existing protections. The patentability hinges on demonstrating novelty, inventive step, and industrial applicability within South African patent law.

Regional and National Patent Trends:
South Africa historically follows the criteria outlined under its Patents Act (Act 57 of 1978), aligning with the TRIPS Agreement standards. The patent application process emphasizes novelty, inventive step, and utility.

Strategic Positioning:

  • Innovation Position: The patent likely claims a unique molecule or formulation with potential advantages over existing therapies.
  • Lifecycle Management: Patent term extensions are not straightforward in South Africa but can be maximized through new claims or supplementary applications.
  • Potential Challenges: Prior art searches from the medicinal chemistry domain may uncover similar compounds; patent examiners examine such prior disclosures critically.

Infringement Risks and Freedom-to-Operate (FTO):
Companies should analyze overlapping claims in patents from competitors or other innovators. The scope's breadth influences the FTO analysis, especially in core therapeutic areas with dense patent clusters.


Legal and Commercial Implications

Patent Validity Considerations:
South African courts scrutinize novelty and inventive step stringently. The strength of the claims must be supported by detailed descriptions and experimental data to withstand potential opposition or nullity suits.

Market Impact:
A robust patent that claims broad protection establishes a strong barrier against generics and biosimilar entry, extending commercial exclusivity.

Regulatory and Patent Linkage:
South Africa’s Medicines and Related Substances Act does not explicitly link patent status with regulatory approval, but patent status influences market strategy and patent litigation.


Summary of Key Insights

Aspect Key Findings
Patent Type Likely a chemical/pharmaceutical formulation or compound patent
Scope Encompasses compounds, formulations, or methods with therapeutic utility
Claims Include independent claims covering novel compounds or processes, with dependent claims narrowing scope
Patent Landscape Dense with prior art, requiring careful claim drafting for enforceability
Market & Legal Outlook Provides critical market exclusivity; validity depends on novelty and inventive step assessment

Key Takeaways

  • Claim Breadth and Specificity:
    Ensure that independent claims are adequately broad to maximize market coverage yet sufficiently supported to withstand validity challenges.

  • Landscape Awareness:
    Monitor related patents in major jurisdictions to understand overlapping rights and avoid infringement.

  • Strategic Positioning:
    Leverage the patent's scope for competitive advantage, especially by securing broad claims and continuous improvement through new filings.

  • Legal Preparedness:
    Regularly review claim language and patent prosecution history to preempt invalidation or contestations.

  • Regulatory & Commercial Planning:
    Align patent strategies with regulatory pathways, especially considering the potential for patent term adjustment or extensions through supplementary filings.


FAQs

  1. What is the significance of the claims in South African patent ZA202100373?
    The claims define the scope of legal protection, determining what specific compounds, formulations, or methods are protected against unauthorized use.

  2. How does South Africa's patent law impact the enforceability of this patent?
    South Africa's patent law requires claims to be novel, non-obvious, and useful. Proper claim drafting and detailed description are essential to defend enforceability.

  3. What are common challenges faced in the patent landscape for pharmaceuticals in South Africa?
    Challenges include prior art discovery, patent invalidity claims, and infringement disputes further complicated by dense patenting in specific therapeutic domains.

  4. Can this patent prevent generic entry in South Africa?
    If granted with broad claims, it can serve as a barrier to generic entry during its validity term, typically 20 years from filing, subject to maintenance fees.

  5. How does the patent landscape influence R&D investment in South Africa?
    A strong patent environment encourages innovation by providing exclusivity, but heavy overlapping patents may restrict freedom-to-operate, influencing R&D planning.


References

[1] South African Patents Act, Act 57 of 1978.
[2] WIPO Patent Data and Classification, adapted for South African context.
[3] Prior art documents and related patents (private databases).
[4] South African Patent Examination Guidelines, 2022.
[5] Industry reports on pharmaceutical patenting trends in South Africa.


In conclusion, South African patent ZA202100373 likely covers a novel pharmaceutical compound or formulation with specific claims designed to confer exclusive rights. Its robust claim scope and strategic positioning in the patent landscape are vital for maximizing commercial advantage and safeguarding against infringement. Continuous patent portfolio management, landscape monitoring, and legal vigilance are essential to capitalize on this invention's potential in South Africa's evolving pharmaceutical market.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.